PURR
$6.05
Market ClosedAs of Mar 17, 8:00 PM UTC
Hyperliquid Strategies Inc., through its subsidiary, operates as a a biotechnology company that owns a platform for biologic medicines of single or bifunctional action.
Recent News
Hyperliquid Strategies Q2 Earnings Call Highlights
Hyperliquid Strategies (NASDAQ:PURR) executives used the company’s second fiscal quarter earnings call to reiterate that the firm operates as a digital asset treasury company focused on holding the HYPE token, while outlining recent capital deployment activity, a financial loss driven largely by tok
Nasdaq-Listed Hyperliquid DAT Announces Purchase of $25 Million Worth of HYPE Tokens
Hyperliquid StrategiesHYPE token purchasePURR stock priceHyperliquid earnings Q4 2025crypto treasury companies
KB Home downgraded, Costco upgraded: Wall Street's top analyst calls
KB Home downgraded, Costco upgraded: Wall Street's top analyst calls
KB Home downgrade, Costco upgraded: Wall Street's top analyst calls
KB Home downgrade, Costco upgraded: Wall Street's top analyst calls